Compare HCA Health Inc (HCA) vs Nutanix Inc (NTNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Nutanix Inc — how do they compare? HCA Health Inc trades at $372.67 (market cap $82.17B), while Nutanix Inc trades at $53.91 (market cap $14.90B). The key difference: HCA Health Inc is far larger — about 5.5× Nutanix Inc's market cap, and HCA Health Inc pays a 0.84% dividend while Nutanix Inc pays none. Which is the better fit depends on your goals.
| HCA | NTNX | |
|---|---|---|
Market Cap | $82.17B | $14.90B |
Sector | Health | Technology |
52-Week High | $545.13 | $81.12 |
52-Week Low | $334.32 | $34.41 |
Enterprise Value | $131.08B | $14.41B |
Dividend Yield | 0.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.
The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.
Nutanix (NTNX) trades at $55.11, showing minimal daily change. The stock exhibits a bullish technical trend, supported by strong earnings beats in recent quarters, including Q1 2026 EPS of $0.47 versus $0.36 expected. Revenue growth is projected to increase from $2.54 billion in 2025 to $2.7 billion in 2026, with net income margin improving to 10.03%. Positive sentiment is fueled by recent news, such as the NVIDIA certification for its Unified Storage solution, highlighting its position in AI infrastructure.
The outlook for NTNX is positive, driven by consistent earnings outperformance and strategic positioning in hybrid multicloud and AI markets. Key opportunities include expanding profit margins and leveraging partnerships. Risks involve competitive pressures in cloud computing and reliance on enterprise spending. The consensus analyst price target of $57.80 suggests moderate upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →
